obesity treatment

New Oral Weight-Loss and Diabetes Drugs in 2026: What the Research Shows

by

How Semaglutide Works as oral Weight Loss drugs and in Type 2 Diabetes For years, injectable medicines dominated the conversation around modern weight-loss treatment. That picture is changing rapidly in 2026. New oral weight loss drugs are now available, while researchers are also testing completely different approaches that target metabolism and skeletal muscle. One of … Read more

Who Benefits Most From Weight-Loss Drugs Like Wegovy and Mounjaro?

by

New study reveals lifelong use of weight-loss drugs like Mounjaro and Wegovy may be necessary A New Study Offers Clues About Why GLP-1 Weight Loss Varies Wegovy and Mounjaro have changed the way doctors approach obesity treatment. Yet one question remains common: why do some people lose much more weight than others on these medications? … Read more

Wegovy HD 7.2 mg: What the FDA Approval Means for Weight Loss Treatment

by

FDA Approves New High-Dose of Wegovy HD 7.2 mg On March 19, 2026, the U.S. Food and Drug Administration approved Wegovy HD, a 7.2 mg once-weekly injectable dose of semaglutide, for certain adults with obesity or overweight plus at least one weight-related condition. The higher dose gives eligible patients another treatment option when clinically appropriate. … Read more